NasdaqGS - Nasdaq Real Time Price USD

Outset Medical, Inc. (OM)

2.5500 +0.0900 (+3.66%)
At close: April 24 at 4:00 PM EDT
2.5900 +0.04 (+1.57%)
Pre-Market: 8:18 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
130,376.0000
130,376.0000
115,375.0000
102,602.0000
49,935.0000
Cost of Revenue
101,376.0000
101,376.0000
97,542.0000
94,994.0000
62,972.0000
Gross Profit
29,000.0000
29,000.0000
17,833.0000
7,608.0000
-13,037.0000
Operating Expense
198,770.0000
198,770.0000
178,852.0000
138,127.0000
104,430.0000
Operating Income
-169,770.0000
-169,770.0000
-161,019.0000
-130,519.0000
-117,467.0000
Net Non Operating Interest Income Expense
-2,504.0000
-2,504.0000
-275.0000
-1,217.0000
-2,365.0000
Other Income Expense
--
--
-1,367.0000
--
-1,660.0000
Pretax Income
-172,274.0000
-172,274.0000
-162,661.0000
-131,736.0000
-121,492.0000
Tax Provision
523.0000
523.0000
295.0000
199.0000
--
Net Income Common Stockholders
-172,797.0000
-172,797.0000
-162,956.0000
-131,935.0000
-79,324.0000
Diluted NI Available to Com Stockholders
-172,797.0000
-172,797.0000
-162,956.0000
-131,935.0000
-79,324.0000
Basic EPS
-3.48
--
-3.38
-2.89
-4.85
Diluted EPS
-3.48
--
-3.38
-2.89
-4.85
Basic Average Shares
49,588.0000
--
48,161.0000
45,589.0000
16,358.0000
Diluted Average Shares
49,588.0000
--
48,161.0000
45,589.0000
16,358.0000
Total Operating Income as Reported
-169,770.0000
-169,770.0000
-161,019.0000
-130,519.0000
-117,467.0000
Total Expenses
300,146.0000
300,146.0000
276,394.0000
233,121.0000
167,402.0000
Net Income from Continuing & Discontinued Operation
-172,797.0000
-172,797.0000
-162,956.0000
-131,935.0000
-121,492.0000
Normalized Income
-172,797.0000
-172,797.0000
-161,876.0700
-131,935.0000
-119,832.0000
Interest Income
10,171.0000
10,171.0000
3,291.0000
498.0000
526.0000
Interest Expense
12,675.0000
12,675.0000
3,566.0000
1,715.0000
2,891.0000
Net Interest Income
-2,504.0000
-2,504.0000
-275.0000
-1,217.0000
-2,365.0000
EBIT
-159,599.0000
-159,599.0000
-159,095.0000
-130,021.0000
-118,601.0000
EBITDA
-153,789.0000
-153,789.0000
-153,926.0000
-124,859.0000
-115,442.0000
Reconciled Cost of Revenue
101,376.0000
101,376.0000
97,542.0000
94,994.0000
62,972.0000
Reconciled Depreciation
5,810.0000
5,810.0000
5,169.0000
5,162.0000
3,159.0000
Net Income from Continuing Operation Net Minority Interest
-172,797.0000
-172,797.0000
-162,956.0000
-131,935.0000
-121,492.0000
Total Unusual Items Excluding Goodwill
--
--
-1,367.0000
--
-1,660.0000
Total Unusual Items
--
--
-1,367.0000
--
-1,660.0000
Normalized EBITDA
-153,789.0000
-153,789.0000
-152,559.0000
-124,859.0000
-113,782.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
--
Tax Effect of Unusual Items
--
--
-287.0700
--
--
12/31/2020 - 9/15/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LUNG Pulmonx Corporation
7.52
+0.27%
 
NARI Inari Medical, Inc.
38.18
+2.88%
 
TCMD Tactile Systems Technology, Inc.
15.04
+3.23%
 
SGHT Sight Sciences, Inc.
5.62
-0.35%
 
SWAV Shockwave Medical, Inc.
328.87
+0.10%
 
CLPT ClearPoint Neuro, Inc.
5.32
-3.27%
 
CUTR Cutera, Inc.
1.9600
-8.84%
 
TMDX TransMedics Group, Inc.
88.88
-1.90%
 
IRTC iRhythm Technologies, Inc.
116.43
+0.08%
 
PEN Penumbra, Inc.
206.15
+0.22%